RecruitingPhase 3NCT07721961

A Study of MI078 for Postpartum Depression

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Clinical Trial of MI078 Capsules for the Treatment of Patients With Postpartum Depression


Sponsor

Nanjing Minova Pharmaceutical Co., Ltd.

Enrollment

200 participants

Start Date

Jul 10, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This is a multicenter, randomized, double-blind, placebo-controlled trial consisting of an experimental drug group and a placebo group, each enrolling 100 participants. The objective of this study is to assess the efficacy and safety of MI078 capsules for the treatment of postpartum depression.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called MI078 capsule and a drug called Placebo of MI078 capsules for people with postpartum depression (ppd). The study is currently recruiting participants at 36 locations. People eligible for this study include women aged 18 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMI078 capsule

MI078 capsule for 3 days

DRUGPlacebo of MI078 capsules

Placebo for 3days


Locations(36)

The Second Affiliated Hospital of Anhui Medical University

Hefei, Anhui, China

Chongqing Three Gorges Hospital

Chongqing, Chongqing Municipality, China

The Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China

Xiamen Xianyue Hospital

Xiamen, Fujian, China

Gansu Provincial Hospital of Traditional Chinese Medicine

Lanzhou, Gansu, China

The First Affiliated Hospital of Jinan University

Guangzhou, Guangdong, China

Zhaoqing Third People's Hospital

Zhaoqing, Guangdong, China

Guangxi Zhuang Autonomous Region Brain Hospital

Liuzhou, Guangxi, China

Guizhou Provincial People's Hospital

Guiyang, Guizhou, China

Affiliated Hospital of Zunyi Medical University

Zunyi, Guizhou, China

Hainan Anning Hospital

Haikou, Hainan, China

The First Hospital of Hebei Medical University

Shijiazhuang, Hebei, China

The Second Hospital of Hebei Medical University

Shijiazhuang, Hebei, China

Shiyan Taihe Hospital

Shiyan, Hebei, China

Xingtai People's Hospital

Xingtai, Hebei, China

The Second Affiliated Hospital of Xinxiang Medical University (Henan Mental Health)

Xinxiang, Henan, China

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China

Zhengzhou Ninth People's Hospital

Zhengzhou, Henan, China

Zhumadian Psychiatric Hospital

Zhumadian, Henan, China

Renmin Hospital of Wuhan University

Wuhan, Hubei, China

Hunan Brain Hospital

Changsha, Hunan, China

Zhuzhou Third Hospital (Zhuzhou Psychiatric Hospital)

Zhuzhou, Hunan, China

Wuxi Mental Health Center

Wuxi, Jiangsu, China

Xuzhou Dongfang Hospital

Xuzhou, Jiangsu, China

Ganzhou Third People's Hospital

Ganzhou, Jiangxi, China

The First Affiliated Hospital of Nanchang University

Nanchang, Jiangxi, China

Shandong Daizhuang Hospital

Jining, Shandong, China

Linfen Central Hospital

Linfen, Shanxi, China

Xi'an Mental Health Center

Xi’an, Shanxi, China

Sichuan Provincial People's Hospital

Chengdu, Sichuan, China

The Affiliated Hospital of Southwest Medical University

Luzhou, Sichuan, China

Huzhou Third People's Hospital

Huzhou, Zhejiang, China

Kangning Hospital Affiliated to Ningbo University

Ningbo, Zhejiang, China

The First Affiliated Hospital of Ningbo University

Ningbo, Zhejiang, China

Beijing Anding Hospital, Capital Medical University

Beijing, China

Beijing Huilongguan Hospital

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07721961


Related Trials